Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CardioComm SolutionsTSXV:EKG OCF Margin % is -96.43% as of Dec. 2025. The stock has 9 warning signs investors should review. Among 665 Healthcare Providers & Services companies, CardioComm Solutions ranks worse than 93.98% on this metric.
The historical rank and industry rank for CardioComm Solutions's OCF Margin % or its related term are showing as below:
TSXV:EKG'
s OCF Margin % Range Over the Past 10 Years
Min: -166.54 Med: -14.94 Max: 5.52
Current: -166.54
During the past 13 years, the highest OCF Margin % of CardioComm Solutions was 5.52%. The lowest was -166.54%. And the median was -14.94%.
TSXV:EKG's OCF Margin % is ranked worse than 93.98% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: 8.29
vs TSXV:EKG: -166.54
CardioComm Solutions OCF Margin % Related Terms
CardioComm Solutions OCF Margin % Historical Data
* Premium members only.
The historical data trend for CardioComm Solutions's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSXV:EKG vs VEEV, BTSG, TEM: OCF Margin % Comparison
For the Health Information Services subindustry, CardioComm Solutions's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CardioComm Solutions OCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, CardioComm Solutions's OCF Margin % distribution charts can be found below:
* The bar in red indicates where CardioComm Solutions's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CardioComm Solutions (TSXV:EKG) has a OCF Margin % of -96.43% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on CardioComm Solutions and its competitors. According to the industry distribution chart, CardioComm Solutions ranks #625 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 94%.
Is CardioComm Solutions' OCF Margin % too high?
CardioComm Solutions' current OCF Margin % is -96.43%. Based on the distribution chart, CardioComm Solutions ranks #625 out of 665 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does CardioComm Solutions' OCF Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, CardioComm Solutions ranks #625 out of 665 companies for OCF Margin %. This places CardioComm Solutions in the lower half of its industry. The industry median OCF Margin % is 8.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Providers & Services company?
The median OCF Margin % among Healthcare Providers & Services companies is 8.29, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on CardioComm Solutions and its competitors. For the Healthcare Providers & Services industry, the median OCF Margin % is 8.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CardioComm Solutions's current OCF Margin % is -96.43%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CardioComm Solutions stock overvalued right now?
CardioComm Solutions (TSXV:EKG) has a current OCF Margin % of -96.43%. The current OCF Margin % is -96.43%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For CardioComm Solutions (TSXV:EKG), the current OCF Margin % is -96.43% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CardioComm Solutions Inc develops software, hardware and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. The Company has one operating segment, which involves the development of software and the sale of ECG recording equipment and ECG reading services for the cardiology field. Substantially all the Company's operations, assets, and employees are in Canada. Revenue is earned in Canada and the United States. Its products are GEMS Sirona, GEMS WIN, Trident Pro 40L, HeartCheck CardiBeat - Mobile ECG Device, HeartCheck SMART Monitoring, and Others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:EKG has been successfully added to your 
